Equities

Palatin Technologies Inc

Palatin Technologies Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.30
  • Today's Change0.14 / 12.07%
  • Shares traded338.55k
  • 1 Year change-35.00%
  • Beta0.9445
Data delayed at least 15 minutes, as of Nov 09 2024 01:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
ASSETS
Cash And Short Term Investments9.531130
Total Receivables, Net02.921.78
Total Inventory00.530.94
Prepaid expenses0.100.480.44
Other current assets, total0.151.411.49
Total current assets9.771635
Property, plant & equipment, net0.921.561.42
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets0.060.060.06
Total assets111836
LIABILITIES
Accounts payable4.104.303.16
Accrued expenses4.576.877.25
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.050.110.10
Other current liabilities, total0.943.865.75
Total current liabilities9.661516
Total long term debt00.050.15
Total debt0.050.150.25
Deferred income tax------
Minority interest------
Other liabilities, total1.202.633.39
Total liabilities111820
SHAREHOLDERS EQUITY
Common stock0.180.120.09
Additional paid-in capital441416404
Retained earnings (accumulated deficit)(442)(416)(388)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total--0(15)
Total equity(0.11)0.1316
Total liabilities & shareholders' equity111836
Total common shares outstanding18129.27
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.